Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum The Canadian Bioceutical CBICF

MPX Bioceutical Corp is a Canada based company involved in the natural health products industry. It is engaged in the manufacture and distribution of nutraceuticals to the North American marketplace and providing financial and business expertise to emerging corporations primarily in the pharmaceutical, medical and biotechnology industries. The company provides management, staffing, procurement,... see more

GREY:CBICF - Post Discussion

The Canadian Bioceutical > Is it wise to buy MPX or better to buy iAnthus?
View:
Post by Oasisjunior on Jan 07, 2019 5:09pm

Is it wise to buy MPX or better to buy iAnthus?

Comment by Mike411Ontario on Jan 07, 2019 6:26pm
MPX is a better buy IMO example; MPX 3000 * .1673 = 501.9 shares of iA/MPX plus 300 shares of MPXI (unknown price) Right now 3000 shares of MPX = $2160US iAnthus 501.9 shares = $2284US that is about 5.5% more at todays price. Plus the 300 shares of MPXI If iA has higher gains before the closing it will be better. Makes sense right, hope this helps.  Mike
Comment by Steve44g on Jan 07, 2019 7:54pm
I'm pretty sure the deadline has passed to get the free mpxi shares You had to be an mpx shareholder by a certain date in early December I'm not 100% sure put that's usually how it works with these deals And for the premium on the share price of .1673 ian for every mpx share I'm not sure if that applies to the same date or not
Comment by Mike411Ontario on Jan 07, 2019 8:31pm
You know Steve that does sound right regarding the MPXI shares, makes sense. Still MPX is better to buy.  I wonder what the MPXI shares will be priced at?  Can't be much. Any ideas ?
Comment by KLownHouSER on Jan 08, 2019 4:34pm
I believe shareholders of the said record date had a right to vote .   If the deal goes through all mpx shares will convert to ian and mpxi.    Correct me if I’m wrong.    —-and what’s up with the vote??  Status report ?
Comment by SilverGold13 on Jan 08, 2019 4:40pm
This post has been removed in accordance with Community Policy
Comment by KLownHouSER on Jan 08, 2019 4:57pm
Shareholders of record on dec 4 can cast their vote until Jan 11
Comment by Bluesguy on Jan 10, 2019 10:28pm
This post has been removed in accordance with Community Policy
Comment by SilverGold13 on Jan 10, 2019 11:02pm
This post has been removed in accordance with Community Policy
Comment by whipper7 on Jan 11, 2019 10:47pm
   Correct me if im wrong. My understanding is that upon the CLOSE of the deal with MPX and Ianthus that might be January 30th is when share holders on record for that day Jan 30th will recieve the merger deal of .673 of IAN for every share held of MPX. The part that I dont get is the .1 being 10% shares in the new stock MPXI witch will be focused on the over seas markets.Will the shares ...more  
Comment by bogdansz on Jan 08, 2019 1:09am
Just joking GLTA
Comment by bogdansz on Jan 08, 2019 1:10am
Could you let me know how much is 2+2??? Just joking GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities